Moreover, we also found that patients with lymph node metastasis tend to carry loss of heterozygosity at BCAR3 alleles, indicating that BCAR3 likely plays a role in preventing disease progression. Here, BCAR3 is linked to metastatic malignant neoplasm in the lymph nodes.